Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.53%
1,095.53
-5.84
-0.53%
1,101.371,103.631,103.631,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.20%
606.00
-7.35
-1.20%
613.35613.35613.35605.76
SIXE
Energy
SIXE
Energy
SIXE
-0.33%
1,194.91
-3.92
-0.33%
1,198.831,199.681,199.751,187.98
SIXI
Industrials
SIXI
Industrials
SIXI
-0.78%
1,742.28
-13.67
-0.78%
1,755.951,754.061,756.031,740.43
SIXM
Financials
SIXM
Financials
SIXM
-0.42%
635.83
-2.68
-0.42%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
+0.27%
845.83
+2.31
+0.27%
843.52843.35846.40840.16
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.18%
216.33
+0.38
+0.18%
215.95215.95216.52215.25
SIXT
Technology
SIXT
Technology
SIXT
+1.46%
3,184.82
+45.91
+1.46%
3,138.913,189.303,208.543,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.12%
935.46
+1.09
+0.12%
934.37934.72936.04927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.18%
1,459.98
-17.45
-1.18%
1,477.431,474.121,474.121,456.42
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.44%
2,390.77
+10.58
+0.44%
2,380.192,389.342,396.912,380.47
MLYS:NASDAQ
Mineralys Therapeutics Inc
$28.24
-0.86%
(-0.24) 1D
Apr 24, 10:10:43 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MLYS...
Open
$28.40
High
$28.97
Low
$27.66
Mkt. cap
2.29B
Avg. vol.
1.43M
Volume
35.18K
52-wk high
$47.65
52-wk low
$12.59
EPS
-$2.29
Beta
0.69
Shares outstanding
82.40M
No. of employees
76
News stories
From sources across the web
About Mineralys Therapeutics Inc
CEO-
Employees76
Founded2019
Headquarters-
SectorBiotechnology
Last report
Mar 12, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-0.40/ (-0.52 est.)USD
+22.52%beat
Revenue / Estimate
-/ (0.00 est.)USD
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
37.88M
38.28M
31.45M
24.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.57M
8.47M
9.68M
13.88M
Operating expense
44.45M
46.75M
41.13M
38.28M
Total operating expenses
44.45M
46.75M
41.13M
38.28M
Operating income
-44.45M
-46.75M
-41.13M
-38.28M
Other non operating income
-3.00K
-2.00K
4.00K
1.00K
EBT including unusual items
-42.21M
-43.27M
-36.93M
-32.23M
EBT excluding unusual items
-42.21M
-43.27M
-36.93M
-32.23M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-42.21M
-43.27M
-36.93M
-32.23M
Net profit margin
-
-
-
-
Earnings per share
-0.79
-0.66
-0.52
-0.40
Interest and investment income
2.24M
3.47M
4.20M
6.04M
Interest expense
-
-
-
-
Net interest expenses
2.24M
3.47M
4.20M
6.04M
Depreciation and amortization charges
-
-
-
-
EBITDA
-44.43M
-46.73M
-41.12M
-38.27M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more